Mansour Kamal A, Thourani Vinod H, Losken Albert, Reeves James G, Miller Joseph I, Carlson Grant W, Jones Glyn E
Joseph B. Whitehead Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Ann Thorac Surg. 2002 Jun;73(6):1720-5; discussion 1725-6. doi: 10.1016/s0003-4975(02)03527-0.
Chest wall defects continue to present a complicated treatment scenario for thoracic and reconstructive surgeons. The purpose of this study is to report our 25-year experience with chest wall resections and reconstructions.
A retrospective review of 200 patients who had chest wall resections from 1975 to 2000 was performed.
Patient demographics included tobacco abuse, hypertension, diabetes mellitus, alcohol abuse, coronary artery disease, chronic obstructive pulmonary disease, and human immunodeficiency virus. Surgical indications included lung cancer, breast cancer, chest wall tumors, and severe pectus deformities. Twenty-nine patients had radiation necrosis and 31 patients had lung or chest wall infections. The mean number of ribs resected was 4 +/- 2 ribs. Fifty-six patients underwent sternal resections. In addition 14 patients underwent forequarter amputations. Immediate closure was performed in 195 patients whereas delayed closure was performed in 5 patients. Primary repair without the use of reconstructive techniques was possible in 43 patients. Synthetic chest wall reconstruction was performed using Prolene mesh, Marlex mesh, methyl methacrylate sandwich, Vicryl mesh, and polytetrafluoroethylene. Flaps utilized for soft tissue coverage were free flap (17 patients) and pedicled flap (96 patients). Mean postoperative length of stay was 14 +/- 14 days. Mean intensive care unit stay was 5 +/- 9 days. In-hospital and 30-day survival was 93%.
Chest wall resection with reconstruction utilizing synthetic mesh or local muscle flaps can be performed as a safe, effective one-stage surgical procedure for a variety of major chest wall defects.
胸壁缺损对胸外科和重建外科医生而言,仍是一个复杂的治疗难题。本研究旨在报告我们25年来胸壁切除与重建的经验。
对1975年至2000年间接受胸壁切除的200例患者进行回顾性研究。
患者人口统计学特征包括吸烟、高血压、糖尿病、酗酒、冠状动脉疾病、慢性阻塞性肺疾病和人类免疫缺陷病毒感染。手术指征包括肺癌、乳腺癌、胸壁肿瘤和严重鸡胸畸形。29例患者发生放射性坏死,31例患者发生肺部或胸壁感染。平均切除肋骨数为4±2根。56例患者接受了胸骨切除。此外,14例患者接受了前半侧肢体截肢。195例患者进行了一期缝合,5例患者进行了延期缝合。43例患者无需使用重建技术即可进行一期修复。采用普理灵网片、玛勒克斯网片、甲基丙烯酸甲酯夹层、薇乔网片和聚四氟乙烯进行胸壁人工合成重建。用于软组织覆盖的皮瓣包括游离皮瓣(17例)和带蒂皮瓣(96例)。术后平均住院时间为14±14天。平均重症监护病房住院时间为5±9天。住院期间及30天生存率为93%。
对于各种严重胸壁缺损,采用人工合成网片或局部肌皮瓣进行胸壁切除与重建可作为一种安全、有效的一期手术。